Abstract
The effects of a Finnish sauna on propranolol pharmacokinetics and on the pharmacodynamics of propranolol and captopril were studied in healthy, young volunteers (2 males, 6 females) in a double-blind, cross-over trial. The subjects received single oral doses of placebo. propranolol (40 mg) or captopril (12.5 mg) in sauna and control sessions at a one-week interval. The sauna sessions consisted of three repetitive 10-min stays in a sauna (85–100°C, relative humidity 25–35%) separated by two 5-min rest periods in a cool room. Sauna bathing started 35, 50 and 65 min after ingestion of the drugs. Venous blood for plasma propranolol measurement were collected before and 15, 30, 45, 60, 75, 90 min and 2, 3, 4, 5, 7 and 24 h after drug intake. The sauna significantly increased the maximum concentration (Cmax 41 vs. 28 ng·ml−1) of propranolol and the mean plasma propranolol concentration 60 and 90 min, and 2 and 3 h after drug administration. It also significantly increased the AUC0–5h (119 vs 71 μg·h·l-1) of propranolol from 0 to 5 hours tmax, t1/2β and AUC0–24h of propranolol did not differ between the control and sauna sessions. The higher propranolol levels during and after the cessation of sauna bathing did not lead to significant changes in blood pressure or heart rate compared to the control period. Captopril had no major effects on these parameters during the post-sauna phase. The results suggest that a sauna may increase the plasma propranolol concentration, but that did not notably affect the blood pressure or heart rate in healthy, young volunteers during the post-sauna phase.
Similar content being viewed by others
References
Arens BG, Böhm ROB, van Kemenade JE, Rahn KH, Baak MA van (1986) Influence of physical exercise on the pharmacokinetics of propranolol. Eur J Clin Pharmacol 31:375–377
Daniell HB, Walle T, Gaffney TE, Webb JG (1979) Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons. J Pharmacol Exp Ther 208:354–359
Davies H (1975) Cardiovascular effects of the sauna. Am J Phys Med 54:178–185
Drettner B (1964) The effect of the sauna bath on the peripheral blood flow. Acta Soc Med Upsal 69:279–290
Duchin KL, Singhvi SM, Willard DA, Migdalof BH, McKinstry DN (1982) Captopril kinetics. Clin Pharmacol Ther 31:452–458
Frank S, Somani SM, Kohnle M (1990) Effect of exercise on propranolol pharmacokinetics. Eur J Clin Pharmacol 39:391–394
Gilmore DA, Gal J, Gerber JG, Nies AS (1992) Age and gender influence the stereoselective pharmacokinetics of propranolol. J Pharmacol Exp Ther 261:1181–1186
Hasan J, Karvonen MJ, Piironen P (1967) Special Reivew. Part II. Physiological effects of extreme heat as studied in the Finnish “sauna” bath. Am J Phys Med 46:1226–1246
Henry JA, Iliopoulou A, Kaye CM, Sankey MG, Turner P (1981) Changes in plasma concentrations of acebutolol, propranolol and indomethacin during physical exercise. Life Sci 28:1925–1929
Hurwitz GA, Webb JG, Walle T, Bai SA, Daniell HB, Gourley L, Loadholt CB, Gaffney TE (1983) Exercise-induced increments in plasma levels of propranolol and noradrenaline. Br J Clin Pharmacol 16:599–608
Iisalo E, Kanto J, Pihlajamäki K (1969) Effects of propranolol and guanethidine on the circulatory adaptation in the Finnish sauna. Ann Clin Res 1:251–255
Kauppinen K, Vuori I (1986) Man in the sauna. Ann Clin Res 18:173–185
Leppäluoto J, Tuominen M, Väänänen A, Karpakka J, Vuori J (1986) Some cardiovascular and metabolic effects of repeated sauna bathing. Acta Physiol Scand 128:77–81
Liedholm H, Melander A (1986) Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation. Clin Pharmacol Ther 40:29–36
Luurila OJ, Kohvakka A, Sundberg S (1989) Comparison of blood pressure response to heat stress in sauna in young hypertensive patients treated with atenolol and diltiazem. Am J Cardiol 64:97–99
McLean AJ, Isbister C, Bobik A, Dudley FJ (1981) Reduction of first-pass hepatic clearance of propranolol by food. Clin Pharmacol Ther 30:31–34
Nies AS, Evans GH, Shand DG (1973) The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol. J Pharmacol Exp Ther 184:716–720
Powis G, Snow DH (1978): The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse. J Pharmacol Exp Ther 205:725–731
Ritschel WA (1986) Area under the blood level-time curve. In: Handbook of Basic Pharmacokinetics, 3rd edn. Drug Intelligence Publications, Hamilton, IL, pp 269–281
Rowell LB (1974) Human cardiovascular adjustments to exercise and thermal stress. Physiol Rev 54:75–159
Rowell LB, Detry J-MR, Profant GR, Wyss C (1971) Splanchnic vasoconstriction in hyperthermic man-role of falling blood pressure. J Appl Physiol 31:864–869
Rowland M, Tozer TN (eds) (1989) Assessment of area. In: Clinical Pharmacokinetics: concepts and applications, 2nd end. Lea & Febiger, Philadelphia London, pp 459–463
Russell MP, Webb JG, Walle T, Daniell HB, Privitera PJ, Gaffney TE (1983) Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther 226:324–329
Schneider RE, Bishop H, Hawkins CF (1979) Plasma propranolol concentrations and the erythrocyte sedimentation rate. Br J Clin Pharmacol 8:43–47
Shand DG (1976) Pharmacokinetics of propranolol: a review. Postgrad Med J 52 [Suppl 4]:22–25
Strömberg C, Vanakoski J, Olkkola KT, Lindqvist A, Seppälä T, Laitinen LA (1992) Exercise alters the pharmacokinetics of midazolam. Clin Pharmacol Ther 51:527–532
Vanakoski J, Strömberg C, Seppälä T (1993) Effects of a sauna on the pharmacokinetics and pharmacodynamics of midazolam and ephedrine in healthy young women. Eur J Clin Pharmacol 45:377–381
Vuori I (1988) Sauna bather's circulation. Ann Clin Res 20:249–256
Wagner JG (1985) Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability. Clin Pharmacol Ther 37:481–487
Walle T, Walle UK, Cowart TD, Conradi EC (1989) Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 46:257–263
Wellstein A, Palm D, Pitschner HF, Belz GG (1985) Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man. Eur J Clin Pharmacol 29:131–147
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vanakoski, J., Seppälä, T. Effects of a finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers. Eur J Clin Pharmacol 48, 133–137 (1995). https://doi.org/10.1007/BF00192738
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00192738